|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.12.25 - 17:21
|
Hims & Hers Health Aktie: Barclays bullish - Risiko bei Compounding geringer als gedacht (Aktiencheck)
|
|
|
London (www.aktiencheck.de) - Hims & Hers Health-Aktienanalyse von Barclays:
Die Analysten von Barclays stufen die Aktie von von Hims & Hers Health Inc. (ISIN: US4330001060, WKN: A2QMYY, Ticker-Symbol: 82W, NYSE-Symbol: HIMS) in einer Ersteinschätzung mit dem Rating "overweight" ein.
Die zuvor bestehenden Bedenken hinsichtlich der Nachhaltigkeit der Compounding-Strategie des Unternehmens seien inzwischen besser verstanden, und die Erwartungen an die Aktie damit realistischer geworden, erkläre Barclays in einer Research-Notiz. [mehr]...
|
|
|
|
|
|
|
|
|
|
|
|
|
04.12.25 - 13:03
|
Hims & Hers Now Serving Customers in Canada (Business Wire)
|
|
|
Follows strategic acquisition of Livewell, a trusted Canadian digital health platform for weight loss care
MONTREAL--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent acquisition of Livewell, a trusted Canadian digital health platform focused on weight loss. Through this expansion, Hims & Hers is well-positioned to usher in the next era of digital health to Canada, bringing its established commitment to providing access to affordable, personalized, and customer-first care.
This investment in Canada will help accelerate an improved, more accessible, and affordable future for individuals seeking weight management treatment. Currently, effective treatment options remain out of reach for many of the two-thirds of Canadian adults who are overweight or living with obesity. This expansion is expected to help accelerate the launch of Hims & Hers' accessible, comprehensive weight ...
|
|
|
04.12.25 - 13:03
|
Hims & Hers Continues Major International Expansion With Official Entry Into Canada (Business Wire)
|
|
|
Follows strategic acquisition of Livewell, a trusted Canadian digital health platform for weight loss care
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform in the United States, is now serving customers in Canada. This entry follows the recent completion of Hims & Hers' acquisition of Livewell, a trusted Canadian digital health platform offering access to a variety of treatments, with a focus on weight loss. Building on a strong foundation in both the US and Europe, the entry into Canada positions Hims & Hers to lead the next era of digital health, centered on providing access to customer-first, affordable, and personalized care.
This strategic move is expected to help accelerate the launch of Hims & Hers' comprehensive weight loss program in Canada next year, timed to align with the first anticipated availability of generic semaglutide anywhere in the world. Almost two-thirds of adults in Canada are overweight or living with obesity, yet ac...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
